http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6835728-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
filingDate 2001-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_273d3bae1939574b1abf168a4c1d80e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfe26fa3be245fa5ee1e67ece994f444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a694553c7041c159f0870994b5fa11c
publicationDate 2004-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6835728-B2
titleOfInvention Drug combination for the treatment of depression and related disorders comprising mirtazapine
abstract The invention relates to a combination comprising an amount of mirtazapine, or a pharmaceutically acceptable salt or solvate thereof, and an amount of gepirone, or a pharmaceutically acceptable salt or solvate thereof, optionally in association with one or more pharmaceutically acceptable carriers, whereby the amount of gepirone and the amount of mirtazapine are such that the effect of the composition is more favourable than the added effects of the amounts of each drug separately. This combination can be used in the treatment of depression and related disorders, whereby the invention also provides for a new method of treatment of depression and related disorders.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006039867-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006122127-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010160294-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006039866-A1
priorityDate 2000-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5977099-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9419026-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9843646-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6150353-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5114976-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226458228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129051833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414856084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415783067

Total number of triples: 48.